Company

Eucrates Biomedical Acquisition Corp

Headquarters: New York, NY, United States

CEO: Mr. Parag Phoolchand Saxena MBA, MS

NASDAQ: EUCR

Market Cap

$42.2 Million

USD as of May 1, 2023

Market Cap History

Eucrates Biomedical Acquisition Corp Categories

United States Financials Shell Companies
United States Financials United States Shell Companies

Eucrates Biomedical Acquisition Corp market capitalization over time

Evolution of Eucrates Biomedical Acquisition Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Eucrates Biomedical Acquisition Corp

Top Competitors by Market Capitalization

Industry: Shell Companies
Company Market Cap (USD)
Pershing Square Tontine Holdings, Ltd. $4.03 B
Soaring Eagle Acquisition Corp $2.46 B
SPK Acquisition Corp $2.13 B
Austerlitz Acquisition Corp II $1.97 B
KKR Acquisition Holdings I Corp $1.73 B
Sector:
Company Market Cap (USD)
Berkshire Hathaway $1.072 T
JPMorgan $894.99 B
Visa $668.67 B
Mastercard $509.08 B
Bank of America $414.42 B

Detailed Description

Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Stocks & Indices

Eucrates Biomedical Acquisition Corp has the following listings and related stock indices.


Stock: NASDAQ: EUCR

Details

Headquarters:

250 West 55th Street

Suite 13D

New York, NY 10019

United States

Phone: 212 710 5220